KristenKellyPierceMD
Infectious Disease • Burlington, VTAssistant Professor, Medicine, University of Vermont College of Medicine
Dr. Pierce is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Avenue
Fletcher Allen Health Care
Burlington, VT 05401Phone+1 802-847-2700
Education & Training
University of Vermont Medical CenterFellowship, Infectious Disease, 2006 - 2008- University of Vermont Medical CenterResidency, Internal Medicine, 2003 - 2006
University of Vermont College of MedicineClass of 2003
Certifications & Licensure
NY State Medical License 2024 - 2026
VT State Medical License 2008 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 10 citationsSafety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial.Mary-Claire R Walsh, Mohammed Shafiul Alam, Kristen K Pierce, Marya Carmolli, Masud Alam
The Lancet. Infectious Diseases. 2024-02-01 - 18 citationsImmunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection modelJohn P. Hanley, Huy A. Tu, Julie A. Dragon, Dorothy M. Dickson, Roxana del Rio-Guerra
Nature Communications. 2021-05-24 - 2 citationsImpact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centre.Timothy J Whitman, Cindy D Noyes, Andrew J. Hale, Devika Singh, Stephen G DeVoe
BMJ Open Quality. 2021-02-01
Press Mentions
- UVM Medical Center Completes COVID-19 Vaccine Study EnrollmentJanuary 10th, 2021
- University of Vermont Medical Center Ramps up Phase 3 Trial Investigating AZD1222 COVID-19 Vaccine Candidate: Seeking VolunteersOctober 29th, 2020
NIH Begins Clinical Trial of Live, Attenuated Zika VaccineAugust 22nd, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
